Target Name: OR2A12
NCBI ID: G346525
Review Report on OR2A12 Target / Biomarker Content of Review Report on OR2A12 Target / Biomarker
OR2A12
Other Name(s): Olfactory receptor family 2 subfamily A member 12 | OR2A16P | O2A12_HUMAN | Olfactory receptor 2A12 | olfactory receptor OR7-10 | olfactory receptor, family 2, subfamily A, member 16 pseudogene | olfactory receptor, family 2, subfamily A, member 12 pseudogene | Olfactory receptor OR7-10 | Olfactory receptor, family 2, subfamily A, member 16 pseudogene | OR2A12P | Olfactory receptor, family 2, subfamily A, member 12 pseudogene | olfactory receptor family 2 subfamily A member 12

OR2A12: A G Protein-Coupled Receptor for The Sense of Smell and Immune System

Olfactory receptor family 2 subfamily A member 12 (OR2A12) is a G protein-coupled receptor that is expressed in the olfactory system, which is responsible for detecting and recognizing scents. OR2A12 is a key receptor for the neurotransmitter olfactory neuropeptide (ONP), which is involved in the sense of smell.

OR2A12 is a small molecule that can interact with other G protein-coupled receptors, including GPR91 and GPR82. These interactions can modulate the activity of these other receptors, which can in turn affect a wide range of physiological processes in the body.

One of the key functions of OR2A12 is its role in the sense of smell. Olfaction is the process by which the sense of smell is triggered, and OR2A12 is involved in this process by detecting the presence of scents. When a scent is present, OR2A12 sends a signal to the brain via the olfactory nerve to activate the olfactory system.

OR2A12 is also involved in the regulation of the immune system. It has been shown to play a role in modulating the activity of natural killer cells, which are important for fighting off cancerous cells. OR2A12 has also been shown to interact with the protein PDGF- BB, which is involved in the regulation of cell growth and differentiation.

OR2A12 is a potential drug target for several diseases. For example, it is currently being investigated as a potential treatment for cancer, particularly breast cancer. Studies have shown that high levels of OR2A12 are involved in the development and progression of breast cancer, and that inhibiting OR2A12 activity may be an effective way to treat this disease.

In addition to its potential as a cancer treatment, OR2A12 is also being investigated as a potential treatment for other conditions. For example, it has been shown to be involved in the regulation of pain perception, and has been shown to interact with the pain receptor TRPV1. This suggests that OR2A12 may be an effective way to treat chronic pain conditions.

OR2A12 is also being investigated as a potential biomarker for several diseases. For example, it has been shown to be involved in the regulation of inflammation, and has been shown to interact with the protein NF-kappa-B. This suggests that OR2A12 may be an effective way to diagnose and monitor inflammatory diseases.

In conclusion, OR2A12 is a G protein-coupled receptor that is involved in the sense of smell and the regulation of the immune system. It is a potential drug target and biomarker for several diseases, including cancer and chronic pain conditions. Further research is needed to fully understand its role and potential as a therapeutic agent.

Protein Name: Olfactory Receptor Family 2 Subfamily A Member 12

Functions: Odorant receptor

The "OR2A12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2A12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46